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Abstract
Background: New models of scalable population-based data collection that integrate digital and mobile health (mHealth) data
are necessary.
Objective: The aim of this study was to describe a cardiovascular digital and mHealth electronic cohort (e-cohort) embedded
in a traditional longitudinal cohort study, the Framingham Heart Study (FHS).
Methods: We invited eligible and consenting FHS Generation 3 and Omni participants to download the electronic Framingham
Heart Study (eFHS) app onto their mobile phones and co-deployed a digital blood pressure (BP) cuff. Thereafter, participants
were also offered a smartwatch (Apple Watch). Participants are invited to complete surveys through the eFHS app, to perform
weekly BP measurements, and to wear the smartwatch daily.
Results: Up to July 2017, we enrolled 790 eFHS participants, representing 76% (790/1044) of potentially eligible FHS participants.
eFHS participants were, on average, 53±8 years of age and 57% were women. A total of 85% (675/790) of eFHS participants
completed all of the baseline survey and 59% (470/790) completed the 3-month survey. A total of 42% (241/573) and 76%
(306/405) of eFHS participants adhered to weekly digital BP and heart rate (HR) uploads, respectively, over 12 weeks.
Conclusions: We have designed an e-cohort focused on identifying novel cardiovascular disease risk factors using a new
smartphone app, a digital BP cuff, and a smartwatch. Despite minimal training and support, preliminary findings over a 3-month
follow-up period show that uptake is high and adherence to periodic app-based surveys, weekly digital BP assessments, and
smartwatch HR measures is acceptable.
(J Med Internet Res 2019;21(3):e12143)   doi:10.2196/12143
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Introduction
Background
Despite its great contributions to our understanding of
cardiovascular disease (CVD) and its risk factors, traditional
cohort epidemiology can be costly and time consuming [1-3],
and it has been recently criticized for a lack of integration of “
real world health information, such as activity level, heart rate
(HR) , or home blood pressure (BP) [4]. Recommendations for
launching digital epidemiology have been put forth by a working
group from the National Heart, Lung, and Blood Institute on
Epidemiology and Population Science with the need for
evaluation of scalability and reliability of digital and mobile
health (mHealth) data [5]. The rapid evolution of commercial
mHealth technologies presents a transformational opportunity
for CVD phenotyping outside of the clinical and Research
Center settings [6-8]. Nevertheless, to date, electronic cohorts
(e-cohorts) have largely enrolled middle-aged and younger
volunteers with a low prevalence of CVD and its risk factors
[9]. With the National Institutes of Health’s All of Us Program,
plans to engage substantial numbers of participants electronically
are evolving [10], but, to date, a few ongoing studies have
successfully enrolled participants in mHealth research [9,11].
Furthermore, little is known about how mHealth and digital
CVD phenotypes, such as activity level, relate to other CVD
risk factors and outcomes in middle-aged and older adults [12].
Objectives
In this paper, we describe the design of the electronic
Framingham Heart Study (eFHS). The broad objective of the
eFHS is to add new mobile and digital phenotypes into the rich
Framingham Heart Study (FHS) and leverage its deep CVD
risk factor phenotyping, longitudinal follow-up, and established
relationships with its participants. We plan to compare novel
measures obtained from commonly used commercial mHealth
and digital devices with other gold standard CVD phenotypes
obtained in the FHS Research Center as well as CVD outcomes.
We have developed a custom smartphone app, the eFHS app,
(see Figure 1), that is capable of messaging participants,
administering surveys to collect health history and behavior
updates, and pulling data from co-deployed wearables, including
a digital BP cuff and smartwatch. The research center staff are
deploying the eFHS app and devices and training participants
on system components in the context of their scheduled and
ongoing FHS Research Center examinations. In addition to
describing our approach and methodology, we report the
characteristics of the eFHS participants, rates of adherence to
the eFHS survey, and digital BP and smartwatch research
protocols over the 3 months since deployment.
Figure 1. Screenshots of the electronic Framingham Heart Study app loading screen, questionnaire, and interface with digital health device (blood
pressure monitor).
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Methods
Study Cohort
The eFHS is enrolling participants from the Framingham Heart
Study (FHS) Third Generation Cohort (Gen 3, total n=4095),
multiethnic Omni Group 2 Cohort (Omni 2, total n=410), and
New Offspring Spouse Cohort (NOS, n=103) enrolled from
2002 to 2005, who are examined every 6 to 8 years, with details
previously reported [13]. eFHS is leveraging the in-person NOS
Examination 3 in the Omni 2 in the FHS Gen 3 that began in
April 2016 in the FHS Research Center [14]. eFHS began
enrollment on June 20, 2016, with the smartphone app and a
digital BP cuff for weekly home BP monitoring. A smartwatch
for daily activity and HR monitoring was added on November
17, 2016. The eligible participants were invited to participate
in eFHS as 1 component of the routine research center
examination, and they were allowed to decline the use of both
digital devices. To be eligible for eFHS, English speaking
participants were required to own an iPhone with a compatible
iOS (version 9 or higher), reside in the United States, and be
willing to provide permissions for notifications and data sharing
with the Research Center. All participants provided informed
consent to participate in the eFHS, both as part of the overall
consent for Examination 3 and an electronic consent within the
eFHS app itself (2-level consent, the consent forms are available
on the FHS website [15,16]. The eFHS protocol was reviewed
and approved by the FHS Executive Committee and the
Institutional Review Board at the Boston University Medical
Center.
As of June 2018, enrollment in eFHS is still ongoing, it will
continue until all FHS participants attend Examination 3. From
June 2016 to July 31, 2017, we have enrolled 790 participants
in eFHS. There were 1737 FHS participants examined at the
Research Center. Of these, 1044 FHS participants (60%) owned
a compatible iPhone and were considered eligible for enrollment
in the eFHS (Figure 2). Of those who were ineligible, 359 (21%)
were Android operating system (OS) smartphone owners and
25 (1%) used an iPhone running an iOS version too old to be
compatible with the eFHS app. In addition, 105 eligible FHS
participants (10%) declined participation in eFHS and 149 who
initially agreed did not complete the setup of the app. Of the
enrolled participants, 689 (64%) downloaded the app and paired
the devices in the Research Center with study staff on the day
of their scheduled study examination. A total of 21 eFHS
participants out of the 790 (2%) returned after their examination
for a dedicated eFHS training session and device set up in the
Research Center, and the remainder were provided with study
devices and instructions by study staff and they set up remotely.
Figure 2. Flow diagram depicting the enrollment of participants in electronic Framingham Heart Study and reasons for nonenrollment.
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Study Smartphone Application
We developed a custom smartphone app (Figure 1,Multimedia
Appendix 1) by using Apple’s ResearchKit with the assistance
of an industry partner (CareEvolution). The app was designed
to electronically distribute and collect survey data and
communicate with participants outside of the FHS Research
Center. The app can be downloaded from the App Store. The
study staff assist participants to download the eFHS app, either
via written instruction or via direct assistance in the Research
Center. The first-time the participants downloads the app, they
are prompted to log in and register as an eFHS participant. They
are then asked to provide an electronic informed consent and
provide notification permissions. Health surveys are
administered through the app at baseline and then at 3-month
intervals (Multimedia Appendix 2). The eFHS app also prompts
health access permissions that enable pairing with mobile and
digital health devices, including the smartwatch and BP cuff
distributed to participants. All participants receive a welcome
to the eFHS message, reminders when surveys are due,
notification of new activities, and reminder messages to comply
with study protocols, including weekly home BP measurements
and daily smartwatch use, as appropriate.
Once participants download the eFHS app, they are prompted
to complete surveys that include digital versions of several
standardized assessments performed in the Research Center.
There are 9 baseline surveys (Multimedia Appendix 2) that
request demographic information, as well as information about
level of physical activity (FHS physical activity index),
health-related behaviors (ie, alcohol consumption, smoking),
medication use, mood (Center for Epidemiologic Studies
Depression Scale, CES-D) [17], CVD risk factors, and baseline
CVD and other health conditions. Additional abbreviated
surveys are being distributed at 3, 6, 9, and 12 months after
enrollment. At 3 months, 1 survey is deployed to assess the
level of self-reported physical activity. Additional information,
including a health history update, mood and function
assessments (CES-D), health survey, and a repeat assessment
of physical activity and mobility are planned for the 6-month
digital surveys (Multimedia Appendix 2).
Study Digital Devices
In addition to the eFHS app, eFHS participants are offered 2
digital devices as part of the eFHS: (1) the Nokia-Withings
digital BP cuff model BP-801 (beginning June 2016, Figure 1)
and (2) the Apple Watch Generation 0 (beginning November
2016). The Nokia-Withings BP device was selected because it
is Food and Drug Administration–approved for home BP
monitoring, has been validated (accuracy ±3 mmHg) [18], and
has been used in other digital device studies [9]. The Apple
Watch was selected because of its compatibility with the Apple
iOS, because it is one of the most commonly used wrist activity
monitors capable of both activity and HR monitoring and
because it has been shown to be the most accurate commercial
wrist-worn HR and a highly accurate step monitor [19].
All eFHS participants are instructed on the proper use of the
digital BP cuff and instructed to perform weekly home BP
measurements. When feasible, the research staff ask participants
to perform their first digital BP in the Center to ensure
understanding of the BP protocol and functions of the digital
BP cuff. Participants are provided with written instructions on
the use of the digital cuff as well as proper home BP monitoring
techniques [20]. Participants are asked to take their digital BP
once per week on the same day at about the same time, if
possible. Participants are provided with written BP guidelines
for use to contact their health care provider if readings are
elevated. In 2016, during the study period, Withings was
purchased by Nokia. A new smartphone app (Nokia Health
Mate) was required to sync the digital BP cuff with the eFHS
app. The research staff contacted participants and helped them
download the new app to ensure continued adherence with study
protocols. Additional BP recordings obtained by participants
are also collected and transmitted to the Research Center.
All eFHS participants are instructed on the proper use of the
Apple Watch. When possible, the research staff synchronize
the participant’s smartphone with the eFHS app and Apple
Watch in the research center. When this is not possible, the
participant synchronizes the device at home. Beginning in 2017,
the Apple Watch Generation 0 required an update be installed
on it before it could be paired with any iPhone. Initially,
participants were asked to take the smartwatch home after this
change occurred because of time constraints and were provided
with written instructions. The study staff then obtained dedicated
study iPhones to download this Apple Watch upgrade onto all
study smartwatches before they were deployed. As part of the
eFHS research protocol, participants are asked to wear the
smartwatch daily and are sent home with instructions on proper
smartwatch use and charging.
Study Reminders
Participants receive scripted reminders (Multimedia Appendix
3) through the app at critical points. For example, when joining
the eFHS, a notification message is sent as follows: “Welcome
to the Electronic Framingham Heart Study. During the next two
weeks, please complete your initial surveys available on the
surveys tab below.” Participants also receive messages when
new surveys become available, “There are new surveys available
to complete. Please open the eFHS app and complete them.”
Reminder notifications are sent when surveys come due, for
example, “Reminder: You have surveys to complete” or “You
have surveys due today. Please open the eFHS app and complete
them.” For participants who had some incomplete surveys and
then completed all surveys the following message is sent,
“Thank you for completing all your surveys. Your contribution
is a vital part of our ongoing research efforts! Emily and the
FHS team.”
Data Management
All data acquired as part of the eFHS are stored on the
participant’s mobile device until the participant has a stable data
connection. Then, study data are passively pushed to a secure
cloud server in the United States in a Health Insurance
Portability and Accountability Act compliant fashion (Figure
3). Adherence to study protocols is monitored by the study team.
Data labeled with the participant’s eFHS ID are batched and
transmitted to the FHS Research Center servers. FHS
statisticians perform quality control activities and further prepare
data for analyses.
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Figure 3. Electronic Framingham Heart Study (eFHS) components (eFHS smartphone app, digital blood pressure cuff, and smartwatch) and data
infrastructure. BP: blood pressure; eFHS: electronic Framingham Heart Study.
Study Analyses
Primary eFHS outcome variables include the following: survey,
BP, wearable device, and overall adherence over 12 months. In
prespecified analyses, we will identify predictors of successful
eFHS protocol adherence to inform future mHealth research.
We also plan to explore relations among validated measures of
cardiovascular health obtained in the FHS Research Center
during examination 3, including measures of vascular stiffness
and exercise capacity from formal cardiopulmonary exercise
testing, with home BP, and average daily HR and steps,
respectively.
For the present descriptive analysis, we described the
characteristics of all eFHS participants enrolled as of July 31,
2017 and compared them with exam 3 participants who did not
participate (either ineligible or declined). Baseline characteristics
of all eFHS and other exam 3 participants are presented as means
± standard deviation for continuous variables and as numbers
and percentages for nominal variables.
We examined completion rates of the baseline and 3-month
surveys and use of digital devices at baseline and 3 months. We
restricted our analysis of survey completion to eligible
participants (baseline, n=790) and 3-month surveys (n=790).
We report the proportion with successfully uploaded survey
data (some survey completed, entire survey completed, and no
survey completion) for the digital baseline survey (comprising
9 questionnaires, Multimedia Appendix 2) and survey
completion at 3 months (comprising 1 questionnaire, Multimedia
Appendix 2). Similarly, we examined adherence to weekly home
BP monitoring only among participants who consented to take
the Nokia Withings BP cuff (n=573) as part of the eFHS.
Similarly, we assessed smartwatch use only among participants
who took an Apple Watch and consented to wear it daily as part
of the eFHS (n=405). We examined the weekly proportion of
participants with at least one BP and HR recording, respectively.
Results
Characteristics of Electronic Framingham Heart Study
Participants
Between June 2016 and July 2017, we enrolled 790 participants
in eFHS. Due primarily to a lack of compatible smartphone,
947 additional FHS participants were not enrolled (Figure 2).
eFHS participants were similar to FHS participants who were
ineligible (ie, incompatible smartphone) or declined to
participate in the eFHS with respect to their race. However,
eFHS participants were slightly younger, more likely to be
female, attained a higher level of education, more likely to report
being in excellent health, and were less likely to be affected by
CVD or its risk factors than those who were ineligible or did
not participate (Multimedia Appendix 4).
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Figure 4. Proportion of eFHS participants uploading at least A) one digital BP weekly or B) one heart rate weekly over the 12 weeks following
enrollment.
App and Device Deployment and Adherence
As shown in Multimedia Appendix 5, out of the 790 (85%)
eFHS participants completed all the baseline surveys and an
additional 38 out of the 790 participants (5%) completed some
of the baseline surveys. A total of 470 out of the 790 (59%)
eligible participants completed the 3-month survey. The average
time to complete all of the baseline and 3-month digital surveys
was modest (18 min for the baseline surveys and 2 min for the
3-month survey). Relating to the staggered rollout of study
devices and delayed smartwatch availability, a greater number
of eFHS participants received a digital BP cuff (n=573) than
those who received a study Apple Watch (n=405). We did not
collect data on the reasons why some participants opted to take
1, both, or no smart devices, because of logistical constraints.
However, based on the communications with the FHS Research
Center staff, we believe that choices were partly influenced by
the perceived time burden imposed by home BP or wearable
device use.
Some digital BP or HR data were obtained from 79% (n=626)
of the 790 eFHS participants who elected to take at least one
study device. Just under half (44%) of the participants
(n=156/353, received the BP cuff, smartwatch and app)
transmitted both BP and HR recordings during the 12th study
week. Adherence to the use of the study smartwatch (Figure 4,
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as defined for study purposes as uploading at least one HR value
during the week, was appreciably (about 30% higher) and
consistently higher over the 3 months following enrollment than
the adherence to the use of the digital BP cuff (Figure 4), as
defined as uploading at least one BP value during the week. We
observed slightly higher rates of adherence to BP monitoring
but no significant difference with respect to rates of adherence
to HR monitoring among eFHS participants with a previous
history of hypertension or cardiovascular disease as compared
with those free from hypertension or CVD in our sample
(Multimedia Appendix 6).
Discussion
Study Background and Design
The eFHS is a novel e-cohort embedded in the ongoing
prospective FHS of middle-aged Gen 3 and Omni-group 2 cohort
participants attending an in-person study examination. We have
described the methodology for recruitment of the eFHS cohort,
the characteristics of this cohort after 1 year of enrollment, as
well as survey completion and adherence to a digital BP cuff
and a smartwatch (for once weekly home BP and HR
measurement, respectively) over 3 months of follow-up.
Our decision to target the FHS Gen 3 and Omni 2 cohorts for
participation in the creation of an e-cohort was substantially
informed by 2 previous studies. First, a digital connectedness
survey was conducted in 2014 to quantify internet access and
device use among FHS participants, including computers,
internet, smartphones, wireless devices, and apps [14]. We
received information from 6503 FHS participants: a total of
87% (n=5678) of our participants had internet access and 60%
(n=3907) used smartphones. We observed that 69% (n=2689)
of smartphone users owned iOS (Apple) compatible devices,
22% (n=855) had Androids, and most smartphone users were
FHS Gen 3 participants [14]. Second, in 2016, we conducted a
randomized controlled trial (NCT02531763) among FHS
families using a smartphone app (Moves or Fitbit) and a
wrist-based activity monitor (Fitbit) in the B ehavioral E
conomics F ramingham I ncentive T rial, BE FIT, study [21].
FHS participants randomly assigned to the intervention arm
entered a 12-week game to achieve physical activity step goals.
Among the 200 trial participants, 97% completed the study. The
BE FIT study enabled us to (1) gain experience deploying a
smartphone app and wearable devices, (2) engage FHS
participants in mHealth activities (89% of the intervention arm
and 83% of the control arm agreed or strongly agreed to the
statement “I enjoyed participating”), and (3) determine that
participants were highly likely to adhere to device use over at
least 3 months.
The enrollment and retention rates in epidemiology studies have
declined over the last 2 decades [22,23]. Furthermore, the
financial and logistical burdens associated with traditional
cohort-based epidemiology are substantial [24]. Finally, cohort
participants spend just 4 hours in the research center every 6 to
8 years or a few hours per year with their designed health care
provider, but they spend 5000 waking hours each year making
decisions that can profoundly affect health (eg, to stop smoking,
to engage in regular physical activity, and to take prescribed
medications to treat BP) [25]. Real-world data obtained from
participants over extended periods can potentially enhance
cardiovascular risk factor identification and prediction of
incident CVD [10]. To that end, development of electronic
epidemiological cohorts, or e-cohorts, whereby information is
collected electronically by leveraging Web-based platforms,
smart devices, or smartphone-compatible applications, offer
potentially sustainable alternatives in this era of digitization
[9,26-29].
In contrast to several other e-cohorts that primarily use
Web-based platforms for enrollment and interaction [9,26-29],
we elected to develop a novel app for survey administration and
deploy it for use in the context of a scheduled study exam
conducted at the FHS research center. Electronic surveys
administered using Web-based platforms are fast to administer
and easier to code than smartphone apps [30,31]. In a recent
analysis conducted by the Pew Research Center, general
response rates for study participants using smartphone app-based
surveys were lower than the Web-based surveys (any survey
completed by 76% vs 94%, in app vs Web-based group,
respectively; all surveys completed by 12% vs 17%, in app vs
Web-based group, respectively) [32]. However, smartphone
app-based surveys offer several advantages, including ease of
administration, integration of data from other smart devices,
and collection of real-time responses that may occur outside
the home or office and thereby suffer from less recall bias than
Web-based surveys [32].
Study Enrollment
Just under half (n=790, 48%) of the 1737 FHS participants
enrolled in the eFHS, a rate lower than has been observed in
other e-cohorts (ie, Health eHeart, 78% of registered participants
completed the consent, 86% of consented completed at least
one survey, 37% of consented participants completed all
surveys) [9]. Nevertheless, only 105 participants (10%) of the
1044 FHS participants with a compatible smartphone declined
eFHS participation and the vast majority of FHS Gen 3 and
Omni 2 participants who were eligible agreed to enroll, with
ownership of an Android OS smartphone being the major reason
for not being enrolled (Figure 2). To address this problem, we
have recently developed an eFHS app for the Android OS and
are now actively enrolling these participants into the eFHS.
Furthermore, once enrolled and consented, survey completion
rates are higher than some de novo e-cohorts [33]. We
hypothesize that embedding enrollment in the Research Center
of an ongoing cohort was instrumental in promoting initial
enrollment and facilitating high rates of survey completion
through in-person training.
Study Adherence
Among the 790 eFHS participants, we observed that the high
rates of completion for our eFHS app-administered baseline
survey (90%; 713 participants completed at least some of the
baseline survey) and 3-month survey were 59% (n=470), with
little reinforcement. The high completion rate is notable in light
of the feature that participants needed to keep the eFHS app
open to receive any eFHS notifications, including a reminder
to complete the surveys. The high rates of survey completion
likely resulted from app download in the research center for
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most participants as well as through optimization of our app
survey methodology to avoid respondent fatigue. We optimized
the digital surveys through the use of progress indicators, by
limiting the number of answer options and allowing participants
to complete the questionnaire across multiple sittings and by
restricting the number of questions per survey to 10 to 20 [34].
Compared with other contemporary e-cohorts with ongoing data
collection, our rates of survey completion were higher than that
those in previous studies, including eCARDIA (52% survey
completion) [29] and the Health eHeart Study (37% completed
all surveys and 29% of myHeart participants completed all
surveys) [9]. Our findings suggest that linking e-cohort
enrollment to a traditional research center study visit offers
distinct advantages with regard to higher rates of adherence to
digital health survey completion. We are developing interactive
messaging functionalities as part of an eFHS dashboard in an
effort to boost survey completion and promote long-term
adherence to survey completion.
Digital Device Deployment and Adherence
The majority, 573 (73%), of the 790 eFHS participants agreed
to use a digital BP cuff weekly and over half, 405 out of the
790 participants (51%), agreed to wear a smartwatch daily. The
difference in device acceptance is related to the delayed start
for the smartwatch. Once the smartwatch deployment began,
acceptance of the 2 devices was similar. Adherence to device
use was initially high, likely secondary to the significant
technical support provided to eFHS participants, particularly
those who had their digital devices set up and synchronized
with the eFHS app in the FHS research center. However, digital
BP use waned significantly over the 3 months following
enrollment, with fewer than half of participants uploading a BP
value in the 12th study week. Digital BP adherence rates in our
study were slightly lower than those seen in another recent study,
in which the rate of adherence to twice-monthly home BP
monitoring (iVitality) was 64% over a 6-month period [35]. We
required participants to upload a BP more frequently and our
eFHS sample of 790 participants had a relatively low prevalence
of diagnosed hypertension (24%, n=186), which may have
contributed to the lower rate of study protocol adherence as
compared with this smaller e-cohort study involving participants
enrolled via the Web. This hypothesis appears to be supported
by the slightly higher rate of adherence among participants with
a history of hypertension in our cohort (Multimedia Appendix
5). However, our findings should be interpreted with caution in
light of the limited number of participants with a history of CVD
in our sample.
The rates of smartwatch use were significantly higher than the
rates of digital BP use throughout the first 12 weeks of the study
despite the release of an iOS update during this period that
interfered with uploading HR values from some Apple Watches.
Differences in rates of adherence to the digital BP cuff and
smartwatch are likely attributable to the passive nature of data
acquisition from the smartwatch and the value to participants
from having a functional watch [36].
Study Challenges
Our team encountered several technical challenges as the eFHS
progressed. Participants forced closed the eFHS app
unknowingly, preventing transmission of BP and HR data. We
updated our in-person training and written materials to advise
participants to keep the eFHS app open. The BP cuff
manufacturer Withings changed to Nokia and we encountered
a brief period of difficulty downloading and configuring the BP
app with the device. A new version of the Nokia Health Mate
app was released, and that resolved the problem we encountered.
Finally, there was an iOS update to the Apple Watch that
significantly added to the time to pair the watch and iPhone in
the Research Center with staff support, leading many
participants to opt to take the device and instructions home to
set up independently. The Research Center staff have obtained
dedicated study iPhones to update the watches before the
in-person examinations to speed the synchronization.
Differences between Electronic Framingham Heart
Study and Framingham Heart Study Participants
In a manner consistent with other digital or e-cohorts, as
compared with other Gen 3 and Omni 2 FHS participants who
were ineligible or declined participation, eFHS participants were
younger, more likely to be women, and had more favorable
socioeconomic determinants of health and better self-reported
overall health status and lower prevalence of cardiovascular
risk factors [9,11,26-28]. Our findings mirror Pew data on iOS
device ownership and have implications for recruitment of
participants for the National Institutes of Health’s AllofUS
initiative, as methods to address sampling biases might be
needed to obtain representative data from e-cohorts that are
applicable to the overall US population [10]. We are attempting
to create a more generalizable e-cohort by developing
enhancements to our app, and we will reexamine differences
among eFHS versus other FHS participants who are ineligible
or decline participation after we complete the enrollment of
participants with Android OS–based devices.
Future Directions
The FHS represents a useful setting to define adherence to novel
mobile methods for cardiovascular phenotyping using mobile
and digital devices among older adults at risk for CVD. Once
device deployment and follow-up are complete, we plan to
analyze long-term rates of survey, BP, and wearable device
adherence over 12 months. In subsamples of eFHS participants,
we intend to study the effectiveness of various mHealth
supportive interventions, such as personalized short message
service text messaging, on protocol adherence. Finally, we plan
to leverage the richness of the FHS through in-person
examination completed by all study participants on the day of
their enrollment. We will analyze relations among validated
measures of cardiovascular health, particularly markers of
vascular stiffness and exercise capacity, home BP, as well as
HR and activity. The overarching goal of the eFHS will be to
inform clinical practice and research of how mHealth and digital
health measures relate to cardiovascular health and CVD risk.
Study Strengths and Limitations
Our study findings should be considered in the context of their
strengths and limitations. We are developing an eFHS cohort
from the Gen 3 and Omni 2 (multiethnic) participants who are
presenting to the research center for an in-person scheduled
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examination. In so doing, we have enhanced our ability to enroll
and train participants on app and device use, as well as to
correlate findings from digital devices with the data collected
during the in-person examinations. Furthermore, we were able
to attain high rates of digital survey completion using a novel
smartphone app and acceptable rates of home device use over
3 months, all with limited post enrollment technical support and
minimal use of push notifications or reminders. However, our
study has certain limitations. First, the eFHS cohort largely
comprises middle-aged, white participants—mean age 53 (8)
years—and, enrollment rates, survey completion rates, and
digital device home use adherence rates observed in our study
might not be generalizable to the samples with older cohort
participants or cohorts involving a larger proportion of
individuals of other racial/ethnic backgrounds. Second, the app
was designed for use with the iPhone, the CareEvolution team
has extended the app for Android users who are currently being
enrolled in the study. Third, we restricted our outcomes to survey
completion and adherence to mobile devices at 3-month intervals
for our current analyses. We plan to examine long-term
adherence rates at 6 and 12 months as the study proceeds.
Conclusions
In this paper, we present our ongoing work to develop a new
e-cohort derived from the FHS participants, as well as
characteristics of the study population. We report acceptable
rates of initial enrollment, high rates of home digital survey
completion using a novel eFHS smartphone app, high rates of
home HR monitoring using a smartwatch, and modest rates of
adherence to weekly BP measurement using a digital BP cuff.
Our work and initial findings provide data and show that it is
feasible to embed an e-cohort within an ongoing traditional
epidemiology study and that middle-aged participants are
capable of completing home-based digital surveys and
cardiovascular phenotyping using digital devices in the short
term. Our initial experience is promising, and we look forward
to linking new digital cardiovascular phenotypic data, including
daily activity, sedentary time, average HR, and home BP
collected in eFHS to validated cardiovascular risk factors and
incident cardiovascular outcomes collected in the FHS.
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